The Mission Report

Marcum MicroCap Conference
Thursday, May 30th, 2013 - Grand Hyatt Hotel, New York, NY

Presenting Companies: A-N O-Z


Abtech Holdings, Inc. (ABHD)

Abtech Holdings, Inc. (OTC: ABHD) is an environmental technologies and engineering firm that provides water pollution and contamination solutions to communities, industry and governments. The company’s products are based on polymer technologies capable of removing hydrocarbons, sediment and other foreign elements in stormwater runoff (ponds, lakes and marinas), flowing water (curbside drains, rivers and oceans), and industrial process and wastewater. For more information visit the company’s Web site at

Acorn Energy, Inc. (ACFN)

Acorn Energy, Inc. (NASDAQ: ACFN) is a holding company operating through four portfolio companies that help companies improve productivity, reliability, security,and efficiency. GridSense provides monitoring for all critical points along the electricity delivery system. OMNIMETRIX remotely monitors emergency back-up power generation systems to increase their reliability. US Seismic supplies fiber optic sensing solutions to increase oil/gas production and lower costs. DSIT provides security solutions from underwater threats to naval and marine based energy assets. For more information visit the company’s Web site at

AdCare Health Systems, Inc. (ADK)

AdCare Health Systems, Inc. (NYSE: ADK) provides senior living and health care facility management. The company owns and manages long-term care facilities and retirement communities, where its mission is to provide the highest quality of healthcare services to the elderly through its operating subsidiaries. Services include a broad range of skilled nursing and sub-acute care services. For more information visit the company’s Web site at

Advaxis, Inc. (ADXS)

Advaxis, Inc. (OTC: ADXS) is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology using live, attenuated bacteria. ADXS-HPV is being evaluated in five clinical trials for HPV-associated diseases: recurrent/refractory cervical cancer, locally advanced cervical cancer, head & neck cancer, and anal cancer. For more information visit the company’s Web site at

Amarantus BioScience, Inc. (AMBS)

Amarantus BioScience, Inc. (OTC: AMBS) is focused on developing certain biologics surrounding the intellectual property and proprietary technologies the company owns to treat and/or diagnose Parkinson's disease, traumatic brain injury, ischemic heart disease, and other human diseases. Amarantus owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. For more information visit the company’s Web site at

Aspen Group, Inc. (ASPU)

Aspen Group, Inc. (OTC: ASPU), a nationally accredited, postsecondary education company, offers cost-effective, comprehensive online education. As of March 31, 2013, 87% of Aspen Group’s full-time, degree-seeking students were enrolled in a graduate degree program (master or doctorate degree program). Aspen Group’s fields of study are: school of professional study, school of nursing, school of education, school of management, school of information technology, and the college of arts and sciences. For more information visit the company’s Web site at

Asure Software, Inc. (ASUR)

Asure Software, Inc. (NASDAQ: ASUR) offers cloud-based time and labor management and workspace management solutions designed to enable businesses to control costs associated with labor, real estate and technology. Asure serves clients worldwide through two main product lines: AsureSpace™ workplace management solutions enable organizations to maximize the ROI of their real estate; and AsureForce® time and labor management solutions deliver efficient management of human resource and payroll processes. For more information visit the company’s Web site at

Atossa Genetics, Inc. (ATOS)

Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, is focused on preventing breast cancer through the commercialization of patented, FDA-designated Class II diagnostic medical devices and patented, laboratory developed tests (LDT) that can detect precursors to breast cancer up to eight years before mammography. Atossa markets ForeCYTE Breast Health Test and the ArgusCYTE Breast Health Test, a blood test for recurrence in breast cancer survivors. For more information visit the company’s Web site at

Augme Technologies, Inc. (AUGT)

Augme Technologies, Inc. (OTC: AUGT) and its wholly owned subsidiary, Hipcricket, provide a customer engagement platform designed to help brands, agencies and media properties to engage customers, drive loyalty and increase sales via mobile. Hipcricket's customers connect with consumers across every mobile channel, including SMS, 2D/QR codes, mobile websites, advertising networks, social media and branded apps. Hipcricket's services are used by an array of national and regional brand-name leaders. For more information visit the company’s Web site at

Axion Power International, Inc. (AXPW)

Axion Power International, Inc. (OTC: AXPW) has developed and patented an award-winning next generation energy storage device, positioning the company among industry leaders in the field of lead-carbon energy storage technologies. Axion believes its new PbC battery technology is the only class of advanced battery that can be assembled on existing lead-acid battery production lines throughout the world utilizing the company’s proprietary activated carbon electrodes. For more information visit the company’s Web site at

BioDrain Medical, Inc. (BIOR)

BioDrain Medical, Inc. (OTC: BIOR) has a fully automated, patented, FDA-cleared surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. The STREAMWAY® System automates the collection, measurement and disposal of surgical fluids to reduce overhead costs to hospitals and surgical centers, improve Occupational State and Health Association (OSHA) and other regulatory compliance agencies' safety concerns, and streamline the efficiency of the operating room. For more information visit the company’s Web site at

BioRestorative Therapies, Inc. (BRTXD)

BioRestorative Therapies, Inc. (OTC: BRTXD) develops medical procedures using cell and tissue protocols, primarily involving adult stem cells, to provide minimally invasive cellular-based treatments. BRT is developing: the brtxDISC™ Program, a non-surgical treatment for bulging and herniated discs; the ThermoStem® Program for metabolic disorders (diabetes, heart disease, etc.) and obesity; and the brtx-C Cosmetic Program to increase the production of collagen and fibronectin, proteins essential to combating the aging of skin. For more information visit the company’s Web site at

Blue Calypso, Inc. (BCYP)

Blue Calypso, Inc. (OTC: BCYP) is engaged in the innovation of digital word-of-mouth marketing and advertising. Utilizing its patented platform, BCYP offers brands the ability to use friend-to-friend referrals by empowering their advocates to share brand content with their unique social graph and rewarding sharing and engagement. The company delivers real-time analytics to help brands achieve a measurable ROI for their social media investment, acquire high-value customers and increase sales. For more information visit the company’s Web site at


BOLDFACE Group, Inc. (OCT: BLBK) is a licensing and branding company focused on celebrity beauty licensing. The California-based company was founded by beauty industry veterans Nicole Ostoya and Robin Coe-Hutshing. The company sells its cosmetics and beauty products under the "Kardashian Beauty" brand, and will sell fragrance products by Mario Lopez and beauty and personal care products by Ugly Dolls. For more information visit the company’s Web site at

Bridgeline Digital, Inc. (BLIN)

Bridgeline Digital, Inc. (NASDAQ: BLIN), The Digital Engagement Company™, provides end-to-end digital engagement solutions designed to enable customers to maximize the performance of their mission critical Web sites, intranets and online stores. The company’s iAPPS(R) platform deeply integrates Web Content Management, eCommerce, eMarketing, and Web Analytics to help marketers attract, engage and convert customers across all digital channels. For more information visit the company’s Web site at

Caliber Imaging & Diagnostics, Inc. (LCDX)

Caliber Imaging & Diagnostics, Inc. (OTC: LCDX) is engaged in the design, manufacture, and sale of non-invasive cellular imaging devices to diagnose skin cancer with an optical biopsy. The company’s VivaScope 1500 and VivaScope 3000 confocal imagers acquire, store, retrieve, display, and transfer in-vivo images of tissue and confocal images of the patient’s lesions for review by physicians to assist in forming a clinical judgment. LCDX’s VivaScope 2500 produces images of unstained and unsectioned excised surgical tissue for medical purposes. For more information visit the company’s Web site at

Can-Fite BioPharma (CANFY)

Can-Fite BioPharma (OTC: CANFY) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company’s pipeline is comprised of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases. The company's lead drug, CF101, is in clinical development for the treatment of autoimmune inflammatory diseases. The CF102 drug candidate is being developed for the treatment of liver diseases. For more information visit the company’s Web site at

Cancer Genetics, Inc. (CGIX)

Cancer Genetics, Inc. (OTC: CGIX) is a DNA-based cancer diagnostics company servicing some of the most prestigious medical institutions in the world. The company’s tests target hard-to-diagnose cancers such as hematological, urogenital and HPV-associated cancers. CGIX also provides a comprehensive range of non-proprietary oncology-focused tests and laboratory services. The company’s state-of-the-art reference lab is both CLIA certified and CAP accredited and has licensure from several states including New York State. For more information visit the company’s Web site at

CAS Medical Systems, Inc. (CASM)

CAS Medical Systems, Inc. (NASDAQ: CASM) is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The company's FORE-SIGHT Absolute Cerebral Oximeter provides an accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation. In addition to FORE-SIGHT Oximeters and accessories, the company provides a line of bedside patient vital signs monitoring products, proprietary non-invasive blood pressure monitoring solutions for OEM use, neonatal intensive care supplies and service. For more information visit the company’s Web site at

Cel-Sci Corp. (CVM)

Cel-Sci Corp. (NYSE: CVM) is focused on improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. The company’s lead investigational therapy is Multikine, currently being studied in a pivotal global phase 3 clinical trial. CVM is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients, and a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its LEAPS technology platform. For more information visit the company’s Web site at

Chanticleer Holdings Corp. (HOTR)

Chanticleer Holdings Corp. (NASDAQ: HOTR) owns in whole or part of the exclusive franchise rights to develop and operate Hooters® casual dining restaurants internationally, including in South Africa, Hungary and parts of Brazil. The company has also joint ventured with the current Hooters franchisee in Australia. The company currently owns and operates in whole or part of six Hooters restaurants in its international franchise territories: Durban, Johannesburg, Cape Town and Emperor's Palace in South Africa; Campbelltown in Australia; and Budapest in Hungary. For more information visit the company’s Web site at

China Distance Education Holdings Ltd. (DL)

China Distance Education Holdings Ltd. (NYSE: DL) provides online education in China focusing on professional education. The online courses offered by the company are necessary to pursue careers in China in the areas of accounting, law, healthcare, construction engineering and other industries. DL also offers online test preparation courses to self-taught learners pursuing higher education diplomas or degrees and to secondary school and college students preparing for various academic and entrance exams. DL also offers online foreign language courses and offline business start-up training courses. For more information visit the company’s Web site at

Chromadex Corp. (CDXC)

Chromadex Corp. (OTC: CDXC) is a natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its wholly owned synergistic business units. Products include ingredient technologies, natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting. The company provides seamless science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. For more information visit the company’s Web site at

CIBT Education Group, Inc. (MBAIF)

CIBT Education Group, Inc. (OTCQX: MBAIF) is an education management company focused on the global education market through the ownership and operation of a network of business, technical and language colleges. MBAIF has cooperative joint programs and representative offices in 18 countries. Its wholly owned college subsidiaries include Sprott-Shaw Community College, Acsenda School of Business and King George International College in Canada; and CIBT School of Business and Beihai International College in China. For more information visit the company’s Web site at

Cleveland BioLabs, Inc. (CBLI)

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is a clinical stage biotechnology company establishing a pipeline of compounds primarily focused on oncology applications and mitigation of radiation injury. The company's lead compound is being developed as both a radiation countermeasure and a cancer treatment. CBLI has two operating subsidiaries, Incuron LLC, and Panacela Labs, Inc., as well as strategic relationships with the Cleveland Clinic, Roswell Park Cancer Institute, the Children's Cancer Institute Australia and the Armed Forces Radiobiology Research Institute. For more information visit the company’s Web site at

Coronado Biosciences Inc. (CNDO)

Coronado Biosciences Inc. (NASDAQ: CNDO) is focused on developing novel immunotherapy biologic agents. The company's two principal pharmaceutical product candidates in clinical development are: TSO (Trichuris suis ova or CNDO-201), a biologic for the treatment of autoimmune diseases such as Crohn's disease, ulcerative colitis and multiple sclerosis; and CNDO-109, a biologic that activates natural killer (NK) cells for the treatment of acute myeloid leukemia (AML), multiple myeloma and solid tumors. For more information visit the company’s Web site at

CopyTele, Inc. (COPY)

CopyTele, Inc. (OTC: COPY) develops and acquires patented technologies for the purposes of patent monetization and patent assertion. COPY currently has 66 U.S. Patents and 11 U.S. Patent applications with coverage primarily organized into six patent portfolios in the areas of Key Based Encryption, E-Paper® Electrophoretic Display, Nano Field Emission Display ("NFED"), Micro Electro Mechanical Systems Display ("MEMS"), Loyalty Point Conversion Systems and Window Frame Construction. For more information visit the company’s Web site at

Cyalume Technologies Holdings, Inc. (CYLU)

Cyalume Technologies Holdings, Inc. (OTC: CYLU) designs and manufactures non-pyrotechnic tactical products and training solutions for the militaries and law enforcement agencies around the world, as well as for certain safety markets. The company is the exclusive supplier to the United States and NATO-country militaries for chemical light needs, and operates manufacturing facilities in the United States and France. Through its subsidiary Cyalume Specialty Products, CYLU also manufactures specialty chemical components for various markets. For more information visit the company’s Web site at

CytoSorbents Corp. (CTSO)

CytoSorbents Corp. (OTC: CTSO) is a critical care-focused therapeutic device company using blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. CTSO’s purification technology removes toxic substances from blood and other bodily fluids. The company’s flagship product, CytoSorb®, is approved in the European Union as a safe and effective means to reduce the "cytokine storm" that could otherwise cause massive inflammation, organ failure and death. For more information visit the company’s Web site at

CytRx Corp. (CYTR)

CytRx Corp. (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, is developing an oncology pipeline focused on the clinical development of its tumor-targeting doxorubicin conjugate aldoxorubicin. CYTR also has rights to two additional drug candidates: tamibarotene and bafetinib. The company is expanding its pipeline of oncology candidates based on its proprietary linker platform technology that can be utilized with multiple chemotherapeutic agents. For more information visit the company’s Web site at

Ddd Group Plc (DDDGF)

Ddd Group Plc (OTC: DDDGF) is engaged in creating s3 dimension (3D) visual experiences through its TriDefTM3D solutions, which convert 2D to 3D automatically, and enable delivery to 3D TVs, PCs and mobile devices. Leading brands, including Intel, Samsung, LG Electronics and Sony, license these solutions. Through its network of licensees, DDDGF has shipped more than 26 million of its TriDef 3D products worldwide. For more information visit the company’s Web site at

DecisionPoint Systems, Inc. (DPSI)

DecisionPoint Systems, Inc. (OTC: DPSI) focuses on enabling the mobile workforce to enhance customer satisfaction and accelerate business growth. The company’s strategy to this goal is by making enterprise software applications accessible to the front-line mobile worker at any time, in any location. DPSI combines its software products, application development capabilities, deployment and support services with the latest wireless, and mobile technologies. For more information visit the company’s Web site at

Del Mar Pharmaceuticals, Inc. (DMPI)

Del Mar Pharmaceuticals, Inc. (OTC: DMPI) is developing and commercializing cancer therapies in new orphan drug indications for patients failing modern targeted or biologic treatments. The company's lead asset, VAL-083, is currently undergoing clinical trials in the U.S. as a potential treatment for refractory glioblastoma multiforme, the most common and aggressive form of brain cancer. VAL-083’s clinical research is sponsored by the U.S. National Cancer Institute and is currently approved for the treatment of chronic myelogenous leukemia and lung cancer in China. For more information visit the company’s Web site at

Digital Cinema Destinations Corp. (DCIN)

Digital Cinema Destinations Corp. (NASDAQ: DCIN), also known as Digiplex Destinations, is focused on transforming movie theaters into interactive entertainment centers by combining state-of-the-art digital technology with a variety of content, including live opera, ballet, Broadway shows, sports events, concerts and, on an ongoing basis, major motion pictures. The company currently operates 18 cinemas and 178 screens in several states. DCIN is also a partner in DigiNext, a specialty content joint venture (with Nehst) featuring curated content from festivals around the world. For more information visit the company’s Web site at

Direct Insite Corp. (DIRI)

Direct Insite Corp. (OTC: DIRI) delivers cloud-based e-invoicing solutions for AP, AR and payments automation. DIRI’s Invoices On-Line (IOL) suite is designed to simplify AP and AR processes such as: electronic invoice distribution and submission, purchase order submission, distribution and acknowledgement, invoice processing and validation, line-item matching, approval routing, invoice consolidation, dispute management, e-payment processing and reporting and analysis. For more information visit the company’s Web site at

Document Security Systems, Inc. (DSS)

Document Security Systems, Inc. (NYSE: DSS) develops and provides patented anti-counterfeiting, anti-fraud, authentication and brand protection technologies used by governments, corporations and financial institutions worldwide. DSS’ proprietary technology solutions deter unauthorized scanning and copying, and facilitate authentication of printed documents and packaging. The company also helps to reduce fraud in drug prescription redemptions and health insurance documents. DSS product solutions are protected under U.S. and foreign patent law and under trade secrets. For more information visit the company’s Web site at

DS Healthcare Group, Inc. (DSKX)

DS Healthcare Group, Inc. (NASDAQ: DSKX) is a developer of biotechnology for topical, and nutritional therapies. The company markets its therapies through online and specialty retailers, distributors, cosmetics wholesalers, and salons. DSKX is one of few cosmetic companies to conduct in-house double-blind clinical testing with human volunteers. Its brands include DS Laboratories (, Sigma Skin (, Polaris Research Laboratories ( and The Pure Guild ( For more information visit the company’s Web site at


DURECTCorp. (NASDAQ: DRRX), a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, has a line of late-stage development programs including Remoxy®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. The company’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications and clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information visit the company’s Web site at

Elephant Talk Communications Corp. (ETAK)

Elephant Talk Communications Corp. (NYSE: ETAK) is an international provider of mobile proprietary Software Defined Network Architecture (Software DNATM) platforms for the telecommunications industry. The platforms are applicable to Mobile Network Operators (MNOs) and Mobile Virtual Network Operators (MVNOs), Enablers (MVNEs) and Aggregators (MVNAs), and offer a full suite of applications, including Full OSS/BSS Systems, Delivery Platforms, Support and Managed Services, on-site, cloud, hybrid and S/PaaS solutions. For more information visit the company’s Web site at

Envision Solar International, Inc. (EVSI)

Envision Solar International, Inc. (OTC: EVSI) designs, manufactures and deploys proprietary and architecturally accretive renewable energy systems leveraging a Drag & Drop Infrastructure™ product line. EVSI's flagship products include the patented Solar Tree® array and Solar Tree Socket™ solar shaded parking solutions with EnvisionTrak™, a proprietary and patent pending solar tracking machine; and SunCharge™ Column Integrated Electric Vehicle Charging Stations. For more information visit the company’s Web site at

Fusion Telecommunications International, Inc. (FSNN)

Fusion Telecommunications International, Inc. (OTC: FSNN) provides cloud communications, cloud computing and managed applications solutions to small, medium and large businesses, as well as carriers, worldwide. FSNN’s service platform enables the integration of leading-edge products and services in the cloud, including hosted voice, data, managed network services, Infrastructure as a Service, storage, security, data center services and Emergency Preparedness. For more information visit the company’s Web site at

Galaxy Gaming, Inc. (GLXZ)

Galaxy Gaming, Inc. (OTC: GLXZ) is the world's second largest developer, manufacturer and distributor of casino table games including Lucky Ladies, Texas Shootout, Emperor's Challenge, Deuces Wild, 21+3, Three Card Poker and Bonus Craps. In addition, GLXZ develops innovative and enhanced electronic wagering platforms and systems such as its Bonus Jackpot System, its Inter-Casino Jackpot System, MEGA-Share and the TableMAX e-Table Gaming System. The company distributes its products to casinos worldwide. For more information visit the company’s Web site at

Galena Biopharma, Inc. (GALE)

Galena Biopharma, Inc. (NASDAQ: GALE) is a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. The company’s Abstral® (fentanyl) Sublingual Tablets are a new treatment option for inadequately controlled breakthrough cancer pain. Abstral is approved by the FDA, and is a sublingual (under the tongue) fentanyl tablet indicated only for the management of breakthrough pain in patients with cancer. For more information visit the company’s Web site at

Glyeco, Inc. (GLYE)

Glyeco, Inc. (OTC: GLYE) is a green chemistry company with a patent-pending technology for transforming a hazardous waste into green products. GlyEco Technology™ is capable of cleaning the polluted glycols from all five waste-producing industries: HVAC, textiles, automotive, airline and medical. This technology recycles waste glycol to meet ASTM Type 1 specifications, and enables users to handle the removal of their waste glycol in a responsible and environmentally safe manner. For more information visit the company’s Web site at

GreenHunter Energy, Inc. (GRH)

GreenHunter Energy, Inc. (NYSE: GRH) provides Total Water Management Solutions™ in the oilfield. In addition to licensing of and joint ventures with manufacturers of mobile water treatment systems (Frac-Cycle™), GRH expands capacity of salt water disposal facilities, next-generation modular above-ground storage tanks (MAG Tank™), advanced hauling and fresh water logistics services—including 21st Century tracking technologies (RAMCATTM). For more information visit the company’s Web site at

GSE Systems, Inc. (GVP)

GSE Systems, Inc. (NYSE: GVP) provides a wide range of simulation, training and engineering solutions to the energy and process industries. The company’s products and services are tailored to meet specific client requirements such as scope, budget and timeline. GVP has more than four decades of experience, more than 1,100 installations, and hundreds of customers in more than 50 countries spanning the globe. GSE Systems is headquartered in Sykesville (Baltimore), Maryland, and has offices worldwide. For more information visit the company’s Web site at

The Hackett Group (HCKT)

The Hackett Group (NASDAQ: HCKT) is a global strategic business advisory and business transformation consulting firm providing best practice advisory, benchmarking and transformation consulting services including strategy and operations, working capital management, shared services and globalization advice. HCKT’s REL group offers working capital solutions focused on delivering significant cash flow improvements; the Archstone Consulting group offers Strategy & Operations consulting services; and the Hackett ERP Solutions group provides business application consulting services that help maximize returns on IT investments. For more information visit the company’s Web site at

Health Revenue Assurance Holdings, Inc. (HRAA)

Health Revenue Assurance Holdings, Inc. (OTC: HRAA) provides revenue integrity technology and services for healthcare organizations across the United States. HRAA creates business intelligence products and consulting services to improve the healthcare delivery experience for doctors, nurses and patients. The company’s full suite of solutions include: data analytics software, business intelligence technology, medical coding, auditing, education, revenue cycle consulting and ICD-10 transition solutions. For more information visit the company’s Web site at

Hennessy Advisors, Inc. (HNNA)

Hennessy Advisors, Inc. (OTC: HNNA) is an investment manager of a wide range of both domestic and international equity products. The company manages 16 funds in Domestic Equity, Sector and Specialty, and Balanced and Fixed Income. Hennessy Funds ( offers traditional equity, specialty category and sector funds, and conservative balanced and fixed income products. For more information visit the company’s Web site at

Heska Corp. (HSKA)

Heska Corp. (NASDAQ: HSKA) markets advanced veterinary diagnostic and other specialty veterinary products with a core focus on the canine and feline markets. The company’s offerings include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines. HSKA sells its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors, as well as trade shows, print advertising, and other distribution relationships. For more information visit the company’s Web site at

ImmunoCellular Therapeutics, Ltd. (IMUC)

ImmunoCellular Therapeutics, Ltd. (NYSE: IMUC) is a clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. IMUC is conducting a phase 2 trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. The company’s pipeline also includes ICT-121, a dendritic cell vaccine targeting CD133, and ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells. For more information visit the company’s Web site at

Innovative Food Holdings, Inc. (IVFH)

Innovative Food Holdings, Inc. (OTC: IVFH) is a nationwide provider of direct-from-source specialty foods, including organic foods, healthcare foods and artisanal foods, to the professional foodservice market. IVFH also markets those products directly to the consumer through its Web site. The company has more than 7,000 products that are used by approximately 30,000 of some of the leading professional chefs across the United States. For more information visit the company’s Web site at

Keating Capital, Inc. (KIPO)

Keating Capital, Inc. (NASDAQ: KIPO) is a business development company that specializes in making pre-IPO investments in innovative, emerging growth companies that are committed to and capable of becoming public. KIPO operates as non-controlling investors and does not require board seats and observation rights. The company is managed by Keating Investments, LLC, an SEC-registered investment adviser founded in 1997. For more information visit the company’s Web site at

LCA-Vision, Inc. (LCAV)

LCA-Vision, Inc. (NASDAQ: LCAV) is a provider of laser vision correction services. The company owns and operates 54 LasikPlus® vision centers in the United States: 49 full-service LasikPlus® fixed-site laser vision correction centers and five pre- and post-operative LasikPlus® satellite centers. LCAV uses a 100% bladeless approach and offers individualized treatment by selecting specific technology for each individual’s eyes and the option to customize LASIK surgery experience to a map of the patient’s unique eye. For more information visit the company’s Web site at

LeMaitre Vascular, Inc. (LMAT)

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a provider of devices for the treatment of peripheral vascular disease, develops, manufactures and markets disposable and implantable vascular devices to address the needs of vascular surgeons. LMAT’s products include embolectomy catheters; occlusion catheters; perfusion catheters; carotid shunts to temporarily divert blood to the brain during the removal of plaque from the carotid artery; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. For more information visit the company’s Web site at

Lightbridge Corp. (LTBR)

Lightbridge Corp. (NASDAQ: LTBR) is a U.S. nuclear energy company that develops proprietary, proliferation resistant, next-generation nuclear fuel technologies for current and future nuclear reactor systems. The company also provides comprehensive advisory services for established and emerging nuclear programs. LTBR’s consultants provide integrated strategic advice and expertise across a range of disciplines including regulatory affairs, nuclear reactor procurement and deployment, reactor and fuel technology and international relations. For more information visit the company’s Web site at

Max Sound Corp. (MAXD)

Max Sound Corp. (OTC: MAXD) is focused on developing and launching audio technology software. The company offers Max Sound embedded chip solutions that restore the natural sound field for TV receivers, LCD and plasma TVs, component DVD players/recorders, personal computers, satellite radio receivers, domestic factory installed auto sound, MP3 players, cell phones, and more. It also provides Max Sound dynamic software module, an API for Internet applications to process audio/video content streamed or downloaded by consumers. For more information visit the company’s Web site at

Medifocus, Inc. (MDFZF)

Medifocus, Inc. (OTC: MDFZF) develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia ("BPH"). The company owns two technology platforms with approximately 100 issued and pending U.S. and international patents on which MDFZF has developed two advanced therapeutic products: the Adaptive Phased Array (APA)-1000 system for treatment of breast cancer and the Prolieve® system for the treatment of BPH. For more information visit the company’s Web site at

MGT Capital Investments, Inc. (MGT)

MGT Capital Investments, Inc. (NYSE: MGT), together with its subsidiaries (MGT Gaming, Inc., MGT Sports, Inc., and Medicsight, Inc.) is engaged in the business of acquiring, developing and monetizing intellectual property rights. MGT engages in providing imaging software and hardware devices, and consulting services, operating in three segments; Medicsight Software/Devices, Medicsight Services, and MGT Gaming. For more information visit the company’s Web site at

MVC Capita, Inc. (MVC)

MVC Capita, Inc. (NYSE: MVC) is a business development firm that provides long-term debt and equity investment capital to fund growth, acquisitions and recapitalization of companies in a variety of industries. MVC seeks out investment opportunities in mature, small and middle-market companies in the consumer products, industrial manufacturing and services, food and food service, financial services, value-added distribution, specialty chemicals and security sectors. For more information visit the company’s Web site at

Naked Brand Group, Inc. (NAKD)

Naked Brand Group, Inc. (OTC: NAKD) is a global lifestyle brand focused on enhancing the appearance of the form of the human body with tailored light-weight garments that seamlessly form to the body. Naked is sold in high-end boutiques and department stores throughout North America, including Nordstrom, Holt Renfrew, Boys'co, Kitson, Akira and A donation from every purchase helps to support Project World Citizen, a charity driven to empower and educate the children of Ghana. For more information visit the company’s Web site at

NanoViricides, Inc. (NNVC)

NanoViricides, Inc. (OTC: NNVC) is a development stage company creating a novel nanoviricide® class of drug candidates designed to specifically attack enveloped virus particles and to dismantle them. NNVC is developing drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. For more information visit the company’s Web site at

NeoStem, Inc. (NBS)

NeoStem, Inc. (NYSE: NBS) is engaged in the emerging cellular therapy industry, leveraging a business model that includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization ("CDMO") providing services to clients advancing regenerative medicine product candidates in the regenerative medicine industry; adult stem cell collection and storage services; and therapy development utilizing T-cells for autoimmune and inflammatory conditions. For more information visit the company’s Web site at

NetDimensions Holdings Ltd. (NETDY)

NetDimensions Holdings Ltd. (OTC: NETDY) on a global scale provides performance, knowledge and learning management systems, providing organizations with talent management solutions to personalize learning, share knowledge, enhance performance, foster collaboration, and manage compliance programs for employees, customers, partners and suppliers. The company’s focus is on highly-regulated industries where operational and compliance requirements are particularly complex. For more information visit the company’s Web site at

New Western Energy Corp. (NWTR)

New Western Energy Corp. (OTC: NWTR) is an independent energy company engaged in the acquisition, development, production, and exploration of oil, gas and minerals primarily in North America. The company has acquired working interests in several producing oil wells in the Gulf States, and is in negotiations to acquire land leases for additional properties that have shown favorable characteristics for the discovery of oil, natural gas and other minerals. For more information visit the company’s Web site at

Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) is a biotech company focused on developing immunotherapy products to treat cancers more effectively than current treatments, eliminating toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the United States and Europe. NBWO’s lead program is a 312-patient phase 3 trial in newly diagnosed glioblastoma multiforme (GBM), the most aggressive and lethal form of brain cancer. For more information visit the company’s Web site at

NTS Communications, Inc. (NTS)

NTS Communications, Inc. (NYSE: NTS) provides high-speed broadband services, including Internet access, digital cable TV programming and local and long distance telephone service to residential and business customers in northern Texas and southeastern Louisiana. The Company currently has operations in Texas, Mississippi and Louisiana and also serves customers in Arizona, Colorado, Kansas, New Mexico and Oklahoma. For more information visit the company’s Web site at


For more frequent updates, follow us on Twitter!

Home     About Us     Blog     Investors     IR Services     Market Research     Partners     Contact     Disclaimer

© 2013 Mission Investor Relations. All rights reserved.
3645 Marketplace Blvd.   Suite 130-280   Atlanta, GA 30344   404-941-8975